[Federal Register Volume 89, Number 245 (Friday, December 20, 2024)]
[Notices]
[Pages 104159-104160]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-30482]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-25-24IV]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled ``Comprehensive Evaluation of the
Implementation and Uptake of the CDC Clinical Practice Guideline for
Prescribing Opioids for Pain'' to the Office of Management and Budget
(OMB) for review and approval. CDC previously published a ``Proposed
Data Collection Submitted for Public Comment and Recommendations''
notice on October 1, 2024, to obtain comments from the public and
affected agencies. There were two public comments related to the
previous notice. This notice serves to allow an additional 30 days for
public and affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570. Comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct
written comments and/or suggestions regarding
[[Page 104160]]
the items contained in this notice to the Attention: CDC Desk Officer,
Office of Management and Budget, 725 17th Street NW, Washington, DC
20503 or by fax to (202) 395-5806. Provide written comments within 30
days of notice publication.
Proposed Project
Comprehensive Evaluation of the Implementation and Uptake of the
CDC Clinical Practice Guideline for Prescribing Opioids for Pain--New--
National Center for Injury Prevention and Control (NCIPC), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
Beginning in the 1990s, opioid prescribing rates for pain
management steadily increased until 2010, remained steady until 2012,
and have declined since then. The increase in opioid prescribing rates
corresponded with increases in opioid-involved overdose deaths, which
initially primarily involved prescription opioids (natural and semi-
synthetic opioids and methadone). In response to this emerging crisis,
CDC issued the CDC Guideline for Prescribing Opioids for Chronic Pain--
United States, 2016 (2016 CDC Guideline). Implementing the 2016 CDC
Guideline was associated with reductions in opioid prescribing and
increases in use of non-opioid medications for pain. At the same time,
laws and policies related to prescribing opioids were instituted that
misapplied or were inconsistent with the 2016 CDC Guideline,
potentially contributing to patient harm. In 2022, CDC released the CDC
Clinical Practice Guideline for Prescribing Opioids for Pain--United
States, 2022, (2022 CDC Clinical Practice Guideline) which provided up
to date evidence regarding pain management approaches and re-emphasizes
the need for prescribers to be focused on patient-centered care to
provide effective pain management. CDC is comprehensively evaluating
the uptake, implementation, and outcomes of the 2022 CDC Clinical
Practice Guideline on evidence-based care for pain management to
understand its impact.
To meet CDC's goal for a rigorous, comprehensive evaluation, this
collection is proposing a mixed-method quasi-experimental approach to
evaluate the 2022 CDC Clinical Practice Guideline. The evaluation
includes dissemination and impact of the 2022 CDC Clinical Practice
Guideline through population-wide changes in prescribing practices for
opioids and medications for opioid use disorder. Also, evaluation of
the implementation of the 2022 CDC Clinical Practice Guideline comes
from perspectives of patients, caregivers, clinicians; and leaders from
health systems, payers, professional associations, and medical boards.
CDC will use this information collection to evaluate the
dissemination, impact, and implementation of the 2022 CDC Clinical
Practice Guideline to ensure that Americans have access to safer,
effective ways of managing their pain. CDC requests OMB approval for an
estimated 310 annual burden hours. There are no costs to respondents
other than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response
respondents respondent (in hours)
----------------------------------------------------------------------------------------------------------------
Clinicians............................ Clinician Survey........ 200 1 10/60
Invitation.............. 1000 1 5/60
Follow up Emails........ 1000 1 5/60
Clinician Interview..... 10 1 1
Dentists.............................. Dentist Interview....... 2 1 1
Health System Leaders................. Health System Leaders 3 2 1
Interview.
Payers................................ Payer Interview......... 3 2 1
Professional Association Leaders...... Professional Association 3 2 1
Leaders Interview.
Medical Board Leaders................. Medical Board Leaders 3 2 1
Interview.
Patients.............................. Patient Focus Groups.... 15 3 1
Caregivers............................ Caregiver Focus Groups.. 15 2 1
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Public Health
Ethics and Regulations, Office of Science, Centers for Disease Control
and Prevention.
[FR Doc. 2024-30482 Filed 12-19-24; 8:45 am]
BILLING CODE 4163-18-P